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Venessa Lynn Pinto
Abstract
Extracorporeal membrane oxygenation is challenged by several potential 
complications. Adverse neurologic events such as intracranial hemorrhages, strokes, 
seizures, and brain death are among the most detrimental and even catastrophic 
of ECMO complications. There are several risk factors related to the patients, their 
underlying conditions and the therapy itself that predispose these patients to neu-
rologic injuries. In this chapter, we review different types of neurological complica-
tions, the identification and management of which can be difficult. We will also 
discuss some of the currently available technologies for multimodal neurological 
monitoring as a complement to clinical exam.
Keywords: stroke, hemorrhage, MRI, neuromonitoring, neuroimaging, ECMO
1. Introduction
ECMO is a cardiopulmonary bypass circuit to support patients in severe cardiac 
and/or respiratory failure. It is an advanced life support therapy for patients at high 
risk of dying from their respiratory or cardiac disease. Extracorporeal life support, 
while life-saving in many instances, can pose serious risks and is associated with 
several neurologic complications. In this chapter, we will review some of the more 
common neurologic adverse events seen in patients on extracorporeal membrane 
oxygenation (ECMO), as well as review some of the neuromonitoring modalities 
available for early recognition of neurologic morbidity. Based on a recent report 
from the Extracorporeal Life Support Organization (ELSO), the current survival 
to discharge after ECMO ranges from 28% for adult ECPR patients to 73% for 
neonatal respiratory ECMO [1]. As survival after ECMO improves with advances in 
technologies and patient care, there is ever increasing emphasis placed on reducing 
morbidity experience by survivors.
Majority of the literature on neurologic injuries come from analyses of the ELSO 
Registry and single center experiences. The ELSO registry currently collects limited 
information on presence of seizures (clinical or EEG confirmed), central nervous 
system (CNS) hemorrhages (intraventricular or parenchymal) as determined by 
ultrasound (US), Computed tomography (CT) or Magnetic Resonance Imaging 
(MRI); diffuse ischemia or CNS infarction; need for neurosurgical intervention, 
and brain death on ECMO [2]. In spite of advances in ECMO circuitry, anticoagula-
tion, and clinical management, the rate of occurrence of neurologic injury has not 
changed in recent times [3].
ECMO was first trialed on a neonate and the success with that patient gradu-
ally spread its popularity among the neonatal and eventually pediatric patient 
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populations [4]. The H1N1 influenza pandemic in 2009 is primarily credited for the 
adoption of ECMO in many adult centers and its use in adults has grown exponen-
tially since. While most of the early data came from neonates, more recent studies 
on neurologic injuries in adults are informing care of the ECMO patient. As ECMO 
is becoming more ubiquitously used, this chapter discusses neurologic complica-
tions noted across the age spectrum. However risk factors, types of complications 
and management often vary by patient population, from neonates to adults. Effort 
has been made to specify if certain descriptions are only applicable to a certain age 
group, and information may not be relevant for all ages.
2. Epidemiology
Quantification of the burden of neurologic complications has been difficult due 
to voluntary and retrospective nature of reporting, variability and lack of consensus 
on neuromonitoring and heterogeneous populations.
An ELSO registry analysis of neonates on ECMO from 2005 to 2010 showed that 
20% had some neurologic complications [5]. Non hemorrhagic complications such 
as cerebral infarction, brain death and seizures were far less common than intracra-
nial hemorrhage. A look at the subgroup of neonates with congenital heart disease 
failed to show an association between type of cardiac lesion and CNS injury [6]. 
The pediatric patient population is more heterogeneous than the neonatal group. A 
study by Hervey-Jumper et al. looked at children on ECMO from 1990 to 2009 and 
found that intracranial hemorrhage occurred in 7.4%, cerebral infarction in 5.7% 
and clinical seizures in 8.4% of all patients [7].
A systematic review of studies from 1990 to 2017 found that intracranial hemor-
rhage was the most common type of neurologic injury in adults, followed by acute 
ischemic stroke [8]. Incidence reported varies widely with a range of 2–21% for intra-
cranial hemorrhage and 1–33% for acute ischemic stroke, with a median proportion 
of 5% of patients experiencing hemorrhages and another 5% with stroke. Seizures 
had the lowest incidence of about 2%. The study did find that neurologic injury was 
overall more commonly reported in VA ECMO than VV ECMO. The occurrence of 
neurologic injury significantly increases the in-hospital mortality with median mor-
tality of 96% for hemorrhages, 84% for ischemic strokes 84, and 40% for seizures.
An analysis of the ELSO registry of almost 5000 adult patients on VV ECMO 
found an overall incidence of neurologic complications in 7.1% of patients [3]. Injuries 
included hemorrhage in 42.5%, brain death in 23.5%, stroke in 19.9%, and seizures in 
14.1%. This study also found that in-hospital mortality was much higher (75.8% versus 
37.8%) for patients with neurological injuries. An analysis of the ELSO registry for 
adult patients on VA ECMO, by the same group, found similar findings in the venoar-
terial cohort [9]. A decade’s review of the Nationwide Inpatient Sample, that included 
over 23,000 patients, found that adult patients with acute ischemic stroke and intra-
cranial hemorrhage on ECMO had higher rates of discharge to a long term facility and 
longer length of stay when compared to patients without neurologic injury [10].
A recent international randomized controlled trial, comparing ECMO to 
conventional mechanical ventilation for severe ARDS, showed a very low rate of 
ischemic stroke in the ECMO population [11]. Out of 124 patients randomized to 
receive ECMO, none had ischemic strokes compared to 5% of the patients initially 
randomized to conventional therapy, although there was the option of crossover 
to ECMO for refractory ARDS. It is unclear if this is due to a restrictive inclusion 
criteria of less than 7 days of mechanical ventilation combined with less severe 
hypoxemia and acidosis from early ECMO cannulation. However, the rates of 
hemorrhagic stroke were similar in the two groups.
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3. Cerebral blood flow and oxygenation on ECMO
Cerebral autoregulation is the term used to describe the ability of cerebral 
arterioles to maintain steady cerebral blood flow across a wide range of cerebral 
blood pressure. This is achieved through dilation and constriction of cerebral blood  
vessels in response to fluctuations in mean arterial pressure. This is a complex 
process mediated through neurogenic regulation, involving sympathetic and 
cholinergic mechanisms, myogenic regulation involving smooth muscle tone, 
and metabolic regulation influenced by local concentration of metabolites [12]. 
Cerebral autoregulation can become disrupted focally or globally in pathological 
conditions leading to cerebral ischemia, hemorrhage or edema. These condi-
tions associated with ECMO include vasospasm, severe acidosis, low cardiac 
output states, hypotension and hypertension, reperfusion injury and absence of 
pulsatile flow in VA ECMO. Hypercapnia is associated with cerebral vasodilation 
while hypocapnia causes cerebral vasoconstriction. A rapid decline in paCO2 
after initiation of VV ECMO has been associated with central nervous system 
(CNS) injury [13].
A study by O’Brien using transcranial Doppler (TCD) showed that in patients 
that did not have neurologic injury, cerebral blood flow velocities on ECMO were 
much lower than predicted and returned closer to baseline after decannulation. 
However in patients that did have cerebral hemorrhage on ECMO, supranormal 
flows were noted in the days preceding the event [14]. A more recent multicenter 
study by the same author confirmed lower flow velocities on ECMO but did not 
show a difference in flow velocities in children with cerebral ischemia compared to 
those without. No patients in this study had cerebral hemorrhage [15].
Cannulation of cervical vessels relies on a competent Circle of Willis to allow 
for cerebral perfusion of both hemispheres. Occlusion of vessels can cause 
ipsilateral venous stasis and this venous congestion can lead to venous hyper-
tension and decreased cerebral perfusion. Changes in cerebral blood flow rate 
and volume can contribute to altered cerebral oxygenation as demonstrated by 
cerebral oximetry [12]. Impairments in cerebral autoregulation, based on wavelet 
transform coherence, are associated with findings on neuroimaging and neuro-
logic outcomes [16].
4. Risk factors for neurologic injury
These can be divided into factors prior to initiation of ECMO and factors inher-
ent to ECMO therapy [17]. There are also risk factors for neurological injury after 
ECMO such as ligation or anastomosis of cervical blood vessels. Because CNS injury 
is often multifactorial, and lesions are often detected retrospectively on imaging 
after ECMO, the exact timing of injury can be difficult to determine.
4.1 Pre-ECMO
The underlying physiologic conditions that necessitate ECMO cannulation, such 
as labile hemodynamics, severe hypoxemia and acidosis, refractory hypotension, 
etc., leave the patient vulnerable to neurologic insults. These can alter the mecha-
nisms responsible for maintaining cerebral autoregulation and make the vascu-
lature more susceptible to alterations in systemic blood pressure. Prematurity is 
associated with an increase in intraventricular and intracranial hemorrhage and can 
be a contraindication for ECMO cannulation. A prior history of neurologic injury 
puts one at further risk of adverse cerebrovascular events.
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4.2 ECMO-related
Animal models have demonstrated the effects of carotid artery and jugular vein 
cannulation and ligation on cerebral blood flow [18, 19]. Adults with atherosclerosis 
may develop emboli during arterial cannulation. ECMO cannulae and circuits 
expose a patient to prothrombotic surfaces and the foreign materials often incite an 
inflammatory response. Platelets are consumed in the circuit components leading 
to thrombocytopenia, putting a patient at increased risk of bleeding. Maintaining 
patency of the circuits requires the use of anticoagulation, which needs to be closely 
monitored to avoid complications such as bleeding, or thrombosis and embolism. 
Reperfusion injury is another risk factor after adequate oxygenation and blood flow 
delivery have been ensured following a period of severe hypoxemia. VA ECMO 
cannulation for cardiogenic shock is also associated with non-pulsatile flow which is 
not physiologic. Neurologic exams are often limited for patients on ECMO, con-
founded by sedation and limited mobility, which can lead to delayed diagnosis and 
recognition. A precannulation lactate greater than 10 mmol/L was found to be asso-
ciated with increased odds for ischemic strokes in adults [8]. A history of pre ECMO 
cardiac arrest, need for renal replacement therapy and elevated bilirubin levels were 
associated with increased odds of neurologic injury [3]. A study of neonates found 
that birth weight less than 3 kg, gestational age less than 34 weeks, a history of prior 
ECMO cannulation and severe acidosis were risk factors for neurologic injury [5].
4.3 Veno-arterial (VA) versus veno-venous (VV)
VA ECMO carries with it the increased risk of embolization as blood is directly 
pumped into the arterial system, unlike in VV ECMO where the oxygenated blood 
is returned to the venous system where the lungs can filter thrombi. However, a 
study by Zahraa found that there was no difference in central nervous system com-
plications between pediatric respiratory failure patients supported on VA versus VV 
ECMO [20]. Differential hypoxia, where the arterial oxygen tension is lower in the 
upper half of the body than in the lower half, is a phenomenon occasionally seen in 
patients supported on peripheral VA ECMO that causes cerebral ischemia [21]. For 
pediatric patients on VA ECMO, the incidence of stroke was much lower for trans-
thoracic or central cannulation compared to peripheral cannulation [22]. VA ECMO 
is also unique in that poor cardiac function results in absence of pulsatile flow, with 
potential implications for cerebral autoregulation and vascular reactivity.
4.4 Carotid repair
The right carotid artery and internal jugular vein are commonly sacrificed dur-
ing ECMO cannulation. Taylor et al. showed the feasibility of vascular repair with 
antegrade flow, without increasing the incidence of embolic phenomenon [23]. A 
larger, more recent study of neonates on VA ECMO, showed over 84% patency of 
repaired vessels. While 43% of all patients had a severe brain lesion after ECMO, 
there was no difference in early neurologic outcomes between the groups that 
underwent carotid repair versus carotid ligation [24].
4.5 Extracorporeal cardiopulmonary resuscitation (ECPR)
ECPR is the rapid deployment of VA ECMO for a patient in cardiac arrest, with 
ongoing CPR, prior to the return of spontaneous circulation. A systematic review 
of adult ECPR data showed that a shockable rhythm and duration of CPR were 
significantly associated with a favorable neurologic outcome [25]. A study of the 
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ELSO registry looking at pediatric patients that received ECPR found an overall 
incidence of acute neurologic injury in 22% of patients [26]. The in-hospital 
mortality was high for these patients at 89%. An analysis of neonatal and pediatric 
ECPR events from a multicenter, national registry showed that while only 43.7% 
of patients survived to hospital discharge, the majority of survivors had favorable 
neurologic outcomes [27]. Another study comparing survivors of ECPR and those 
with return of circulation after conventional CPR found comparable neurologic 
outcomes between the two groups, with total duration of cardiac arrest being the 
only predictor of survival [28].
5. Types of neurological complications and their management
There is a wide variety of neurological injuries that are noted after ECMO 
including embolic strokes, hypoxic-ischemic encephalopathy, cerebral infarction, 
intracranial and subarachnoid hemorrhages, seizures, cerebral edema and even 
brain death. Other complications, such as critical illness myopathy, neuropathies, 
delirium, hearing loss, vocal cord paralysis etc. are related to prolonged hospitaliza-
tion and ICU stays, need for prolonged mechanical ventilation or tracheostomy, 
prolonged exposure to sedation, and limited mobility that often accompany ECMO 
runs. In this section of the chapter, we will look at some of the more common 
neurologic complications experienced by patients treated with ECMO.
5.1 Hemorrhagic complications
Intracranial hemorrhage (ICH) is one of the most common adverse neurologic 
events on ECMO, carrying a high mortality rate. It can occur as intraparenchymal, 
intraventricular or subarachnoid hemorrhages. Gestational age at time of ECMO can-
nulation, severe acidosis needing correction, sepsis, need for epinephrine, therapeutic 
hypothermia and need for cardiopulmonary resuscitation (CPR) have been associated 
with intracranial hemorrhage in neonates [29–31]. A longer duration of ECMO, higher 
activated clotting times (ACTs), presence of bleeding at other sites, pre-admission 
antithrombotic therapy, and low platelet counts were associated with hemorrhage in 
adults [32, 33]. Rapid PaCO2 decrease/correction of hypercapnia and renal failure 
at ICU admission were associated with increased intracranial hemorrhage in one 
adult study [13]. In order to detect intracranial hemorrhage while on ECMO, cranial 
ultrasounds are used in neonates while CT imaging is used in children and adults. In 
one observational study, 42% of the cohort underwent withdrawal of life sustaining 
therapy, 18% did not require any intervention and 40% were treated. Treatments 
included hemostatic interventions, ICP management and surgical interventions with 
14% of the cohort uneventfully decannulated [34]. Patients that have clinically signifi-
cant bleeds, with progression of brain injury and little to no improvement on ECMO 
ultimately end up with withdrawal of life sustaining therapies due to poor prognosis 
and risk of progression of the bleed. Patients with very small or clinically insignificant 
hemorrhages can continue their ECMO courses with close neurological monitoring, 
decannulation at the earliest feasible time and possibly lowering of anticoagulation 
parameters while balancing thrombotic risks. Platelets and anti-fibrinolytics may need 
to be administered. Occasionally ECMO circuits can be trialed without any anticoagu-
lation keeping a close eye on the circuit for clots and fibrin deposition. Life-threatening 
hemorrhage can be severe enough to warrant a craniotomy [7, 35]. Hematoma evacu-
ation on ECMO is high risk and carries a high mortality although there are reports 
of patients who survived [34]. There is heterogeneity in practice with drugs used for 
anticoagulation (heparin versus bivalirudin), tests to assess for anticoagulation (TEG, 
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ROTEM, activated clotting time, PT/PTT, heparin assays) and therapeutic targets for 
titration. Further research is needed to help develop guidelines and consensus on best 
practice to minimize and treat bleeding complications on ECMO.
5.2 Ischemic complications
It occurs in about 5–6% of children and adults [8, 36], and is best identified on 
MR imaging. Due to multifactorial etiology for ischemic strokes such as hypoten-
sion, large vessel occlusion, thromboembolism, septic embolism, etc. it is difficult 
to characterize lesions anatomically or to prognosticate based on imaging. Timing 
of injury is also difficult to ascertain. There are conflicting reports on laterality of 
lesions [37] but seem to occur in the middle cerebral artery vascular territory. A 
single center pediatric study found that majority of strokes were bilateral, a few 
were unilateral right sided lesions and no patients had unilateral left sided strokes; 
majority of the lesions were in the anterior cerebral circulation distribution [22]. 
Ischemic lesions are associated with electrographic seizures and decreased survival 
[38]. Asymmetry in regional cerebral saturation or on continuous EEG monitoring 
might be suggestive of focal ischemia. Once detected, hemodynamics should be 
optimized through adequate pump flows on VA ECMO, vasoactives can be used if 
needed, and further neurologic injury should be minimized by avoiding hyperoxia 
and treating seizures.
5.3 Seizures
Although less common than intracranial hemorrhage and stroke, seizures can be 
difficult to recognize if they are nonconvulsive or subclinical. A study of children 
and neonates undergoing ECMO revealed that 18% of patients had electrographic 
seizures, with 61% of those patients having electrographic status epilepticus 
and 83% having exclusively electrographic seizures [39]. Another recent study 
of neonatal and pediatric patients found electrographic seizures in 23% of their 
patients, especially within the first 24 hours of ECMO [40]. Patients with seizures 
had decreased survival to discharge (44% versus 74%). Older studies that reported 
lower incidence of seizures may have missed patients if only clinical seizures were 
reported, as the routine use of continuous EEG monitoring for patients is not yet 
a widespread practice, although recent recommendations advocate for its use in 
ECMO. Given that patients on ECMO are a high risk population, seizures should be 
treated with the help of neurologists.
5.4 Sensorineural hearing loss
Sensorineural hearing loss has been reported in neonatal ECMO graduates with 
a frequency of 3–21% [41]. Diagnosis of congenital diaphragmatic hernia, duration 
of ECMO, and aminoglycoside antibiotic use were associated with hearing loss 
[42]. A follow-up study found that even children diagnosed with hearing loss after 
ECMO can go on to have normal language development [43].
5.5 Myopathy
Prolonged immobilization, sedation and paralytics, hemodynamic instability, all 
contribute to neuromuscular weakness in ECMO patients. Studies have proved that 
active physiotherapy, with early mobilization, is feasible and safe in ECMO patients 
when performed with an experienced, multidisciplinary team [44, 45]. It may also 
shorten hospital duration and improve functional outcomes for patients [46].
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5.6 Delirium
A small study of pediatric cardiac ECMO patients diagnosed delirium in all their 
patients, in 21% of coma-free ECMO days [47]. Use of validated delirium screening 
tools can aid in early recognition and management of delirium. The move to liberate 
ICU patients should include patients on ECMO whenever feasible, with an emphasis 
on delirium prevention.
5.7 Brain death on ECMO
Progressive cerebral edema and large hemorrhages, whether from insults prior 
to cannulation or secondary to complications from ECMO, can ultimately lead 
to brain death in patients supported on ECMO. Diagnosis of brain death can be 
challenging on ECMO, but is important to determine as it is medically and ethically 
unreasonable to continue ECMO for a patient who has met criteria for brain death.
5.7.1 Determination of brain death
The American Academy of Neurology issued guidelines on the determination 
of brain death in adults, most recently revised in 2010 [48]. Similarly the Society of 
Critical care Medicine, American Academy of pediatrics and the Child Neurology 
Society jointly published guidelines for the determination of brain death in children 
and infants in 2011 [49]. The following general criteria apply to all patients under-
going brain death testing, although the specifics may vary by institutional policies. 
Patients should be relatively normothermic, and electrolytes and glucose should be 
within acceptable ranges. Any medications that may interfere with respiratory drive 
and neurologic function must be discontinued, with drug levels obtained if needed. 
The patient must demonstrate absence of all motor function and lack of responsive-
ness to stimuli, except spinal reflexes. Cranial nerve testing should reveal absence 
of pupillary reflexes, corneal reflexes, oculovestibular and oculocephalic reflexes, 
absence of cough and gag reflexes and absent brain stem reflexes.
The apnea test is an important component of brain death testing without which 
ancillary studies such as cerebral angiography, nuclear scanning for cerebral blood 
flow, electroencephalography, transcranial Doppler etc. are required to demonstrate 
absence of blood flow to the brain. The apnea test is performed to demonstrate 
absence of spontaneous respiratory drive in the presence of rising paCO2 levels in 
the blood. The patient is pre-oxygenated with 100% FiO2 and ventilated to achieve 
normocarbia, if possible. A baseline blood gas analysis is obtained. The patient is 
then disconnected from the ventilator and oxygenated via a T-piece or flow-inflat-
ing anesthesia bag. The patient is closely observed for signs of spontaneous respira-
tion or chest rise. Serial blood gases are obtained at every few minute intervals. A 
rise in paCO2 > 60 mmHg and > 20 mmHg above baseline is conclusive of absence 
of respiratory drive. If the patient were to become hypoxic or hemodynamically 
unstable the apnea test should be discontinued and ancillary studies obtained.
5.7.2 Apnea testing on ECMO
While clinical criteria of absence of cortical function and brain stem reflexes 
can be assessed in the usual manner, apnea testing can be difficult on ECMO. A 
proposed method for apnea testing is oxygenating the patient by use of continuous 
positive airway pressure (CPAP) or T-piece or by placing the patient on a self-
inflating anesthesia bag with a PEEP valve, while watching for spontaneous respira-
tions. The oxygenator on the circuit can then be capped. Alternatively, the sweep 
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gas is decreased to 0.5 –1 L/minute and oxygen increased to 100% FiO2 through the 
circuit, without any changes to extracorporeal blood flow [50, 51]. In-line gas moni-
toring on the ECMO circuit can be used to trend venous paCO2, but serial arterial 
blood gas analysis should be used to confirm the lack of ventilation secondary to 
central apnea. For patients on VA ECMO, hemodynamics should be maintained 
through circuit flows and use of vasoactive medications as needed. Patients found to 
be brain dead on ECMO can be considered as candidates for organ donation.
6. Neurological monitoring
There are currently no consensus guidelines for neuromonitoring on ECMO, 
with variations in practice at different institutions. Neuromonitoring may include 
assessment of brain structure or morphology via imaging, assessment of brain 
function via EEG or SSEPs, assessment of cerebral perfusion via cerebral oximetry 
or transcranial doppler, and assessment for neurological injury via biomarkers. 
Bembea and colleagues performed a systematic review of the literature; 39 obser-
vational and case-control studies met inclusion criteria, with most of the literature 
coming from neonatal studies [52]. There was very little data in pediatric and adult 
cohorts, and the study found limited data on the use and effectiveness of monitor-
ing technologies. A recent review by Lin et al. discusses neuromonitoring in the 
neonatal ECMO patient [53].
6.1 Exam
Neuromonitoring of the ECMO patient should begin with daily neurologic 
assessments that are documented in the patients chart. These are limited by reliabil-
ity when performed by multiple providers from different disciplines, however are 
useful for obtaining a daily baseline that can be suggestive of injury when a change 
is noted. This would also require daily sedation holidays for accurate assessments as 
well as using the least amount of sedation to keep the patient safe and comfortable. 
Use of neuromuscular blockade should be reserved for extremely ill patients and 
those whose movement limits ECMO flows. A change in neurologic exam is often 
the trigger for seeking additional information such as through neuroimaging.
6.2 Neuroimaging
Cranial or head ultrasound (HUS) is a mode of imaging limited to neonates and 
infants with open fontanelles. Ultrasound uses high frequency sound waves trans-
mitted via a probe that are reflected back based on the tissue’s composition as well 
as distance from the probe. Changes in tissue density from hemorrhage or ischemia 
will reflect back sound waves differently from surrounding tissue. Cranial ultra-
sounds are portable, easy to use, relatively inexpensive, and do not carry radiation 
risks. Most neonatal ECMO programs will obtain a HUS prior to ECMO cannulation 
as well as daily HUS for the 1st few days on ECMO. While it is best for detecting 
hemorrhages, ischemic changes are harder to interpret on HUS [54]. HUS can also 
give information on changes in ventricular size that would be seen in hydrocepha-
lus. It is not as sensitive as other imaging techniques and a study showed that MRI 
was significantly more sensitive for detection of CNS lesions than HUS alone [55, 
56]. The quality of images depends on the skill level of the ultrasound technician 
and interpretation of acquired images can be subjective and variable. HUS findings 
have not consistently correlated with neurodevelopmental outcomes and should not 
be used for predicting outcomes in neonatal ECMO survivors [37, 56].
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Computed tomography (CT) is a diagnostic imaging modality that utilizes X-Rays 
directed at the patient that are picked up by a detector and sent to a computer to create 
thin 2D image slices, at different tissue depths. Multiple images can then be stacked 
to create a 3D picture. It is the most frequently used imaging modality for diagnosis 
of acute intracranial injury for patients on ECMO. A CT scan can be quickly obtained 
and has better sensitivity and specificity for detecting intracranial hemorrhage that 
might lead to clinical changes in management [53]. A disadvantage is exposure to 
radiation and its associated risks. Transporting a patient on ECMO to a CT scanner in 
the radiology department can be challenging in the absence of a portable scanner that 
can be brought to bedside. ELSO currently recommends a CT scan prior to hospital 
discharge for patients less than 4 years of age and if there is an abnormal neurologic 
exam for patients older than 4 years of age as part of post-ECMO follow up [57].
Magnetic Resonance Imaging (MRI) is a non-invasive technology that creates 
3D anatomic images without exposing the patient to radiation. A strong magnetic 
field is used to force protons in the body into alignment. Then a brief radiofrequency 
pulse stimulates protons causing a change in alignment. The scanner can detect 
electromagnetic energy transmitted as the protons realign. It is reserved for patients 
after decannulation from ECMO, due to MRI incompatible materials in the cannulae 
and circuits. MRI is the most sensitive and specific imaging technique available. 
However it takes much longer time to obtain the study compared to a CT and is more 
expensive. While diffusion-restriction can be seen up to 10 days after acute ischemic 
injury, the optimal timing for obtaining an MRI after ECMO remains unclear [53].
6.3 Electroencephalography (EEG)
While neuroimaging provides information on the structure of the brain, EEG 
provides real-time information on the electrical activity of the brain. Information is 
obtained via electrodes placed on the scalp, connected to a monitor, with very little 
burden to the patient that would include scalp abrasions. Continuous EEG (cEEG) 
monitoring requires technicians to set up the electrodes as well as neurologists to read 
the EEGs, which can be time consuming. Amplitude-integrated EEG (aEEG) com-
presses the raw EEG data from 1 to 2 leads, is easier to set up and interpret, but due to 
lower sensitivity, can be used as a screening tool or in resource limited settings [53]. 
Ischemic and hemorrhagic injuries can predispose a patient to seizures that require 
prompt treatment. Continuous EEG monitoring is important for early identification 
and treatment of subclinical seizures or electrical status epilepticus that may not be 
otherwise detected, although studies are needed to show its benefit in improving long 
term outcomes. EEG monitoring is especially useful in paralyzed patients in whom a 
neurological exam cannot be elicited. EEG can be used to detect early cerebral isch-
emia through loss of fast alpha and beta frequencies to slowing and even suppression 
of all electrical activity as might be seen in an infarct. In 2011, the American Clinical 
Neurophysiology Society deemed ECMO as a high risk clinical scenario in neonates that 
would warrant long term EEG monitoring due to cardiac or pulmonary risks for acute 
brain injury and clinical encephalopathy [58]. This recommendation is supported by 
ELSO in their guidelines for management of neonatal respiratory failure [59]. In their 
2015 consensus statement on continuous EEG in critically ill adults and children, the 
American Clinical Neurophysiology Society recommended continuous EEG monitoring 
for patients treated with pharmacologic paralysis, including patients on ECMO [60].
6.4 Transcranial doppler ultrasound (TCD)
This is a non-invasive, portable test that is based on the Doppler effect. A Doppler 
probe is used to emit high frequency sound waves through the cranium that are reflected 
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back by moving red blood cells in the blood vessels. The difference in frequencies of 
emitted and reflected waves is proportional to the cerebral blood flow. Studies have 
found that TCD velocities (TCDV) are much lower for pediatric patients on ECMO when 
compared to normative values for healthy and critically-ill children [15, 61]. While there 
was no significant association between global TCDV (systolic flow velocity, diastolic 
flow velocity, mean flow velocity) and neurologic injury, increased pulsatility index and 
regional increases in velocities or asymmetries might be predictive of neurologic injury.
6.5 Cerebral near infra-red spectroscopy (NIRS)
NIRS monitoring is a non-invasive technology that uses near-infrared wavelength 
of light that penetrates brain tissue via a scalp electrode. It provides a continuous 
measurement of regional tissue oxygen saturation (rSO2), which is a marker of 
the balance between oxygen delivery and demand in the tissues. When the probe is 
placed on the forehead, it measures cerebral oximetry. An analysis of adult patients 
on VA ECMO showed that cerebral desaturation was common and mortality higher 
for patients with cerebral desaturation compared to those without [21]. A sudden 
decrease in cerebral saturation can be associated with an acute neurological event, 
prompting further investigation. It can also serve as an early predictor of inadequate 
oxygenation and cardiac output especially peri-cannulation [62]. It can influence 
management by prompting a need for increased flows in VA ECMO or alternate 
cannulation strategies if there is differential hypoxia. A very high rSO2 could also be 
suggestive of very poor oxygen extraction and poor neurologic outcomes.
6.6 Biomarkers
Several plasma proteins have been evaluated as potential markers for brain 
injury [63]. These biomarkers include substances associated with glial injury (glial 
fibrillary acidic protein and s-100b), neuronal injury (neuron-specific enolase and 
brain-derived neurotrophic factor) and neuro-inflammation (intercellular adhesion 
molecue-5). Unfavorable neurologic outcomes have been associated with higher 
biomarker concentrations [64], with combinations of biomarkers providing higher 
sensitivities and specificities for detection of neurologic injury. These tests are more 
expensive and require laboratory equipment and processing availability. While 
not currently a routine component of neuromonitoring on ECMO in most institu-
tions, there is potential for further research and applicability if these results can be 
obtained in real time to influence management.
6.7 Somato-sensory evoked potentials (SSEPs)
SSEPs measure electrical signals in the somatosensory cortex after a peripheral 
stimulus, assessing the pathway of neuronal conduction from the peripheral nerve 
to the cortex. They are assessed as normal, abnormal (increased latency) or absent. 
ECMO cannulation is not thought to alter the ability to assess SSEPs from the hemi-
spheres [65]. Small studies have shown an association between abnormal SSEPs 
and poor neurologic outcome after ECMO [66], but the predictive value of evoked 
potentials remains to be determined. In one study, absence of bilateral SSEPs was 
associated with progression to brain death for patients treated with ECPR [67].
6.8 Optic nerve sheath diameter (ONSD)
It is a simple bedside test used to detect elevated intracranial pressure. A  cut-off 
of 5.2 mm is sensitive and specific for intracranial hypertension [68]. Its use in 
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ECMO management is still in its infancy, although a study showed that higher 
ONSD was associated with poor neurological outcome after ECPR [69].
7. Therapeutic hypothermia
Therapeutic hypothermia has been shown to be neuroprotective for term neo-
nates at risk of hypoxic ischemic encephalopathy secondary to perinatal asphyxia. 
However a randomized controlled study out of the United Kingdom did not show 
an improvement in outcomes for neonates on ECMO treated with mild hypothermia 
[70]. On the other hand, therapeutic hypothermia has been associated as a risk fac-
tor for intracranial hemorrhage and should be avoided [30]. In 2015, the American 
Heart Association recommended targeted temperature management of 32–36°C for 
comatose patients with return of spontaneous circulation after cardiac arrest [71]. 
This was also applied to patients who suffered in- hospital cardiac arrest leading to 
ECPR. A more recent large, multicenter, randomized control trial failed to show a 
benefit in survival with favorable neurological outcome for children with in-hospi-
tal cardiac arrest. There is no data to support routine therapeutic hypothermia for 
children undergoing ECPR although maintaining normothermia is still encouraged.
8. Conclusion
Neurologic complications contribute to significant morbidity and mortality for 
patients on ECMO, who constitute a high risk population. There are many modali-
ties currently available for neuromonitoring, and as we gain more experience 
and information through more frequent use, we will be able to develop consensus 
guidelines and protocols to provide better care. A multimodal approach to active 
surveillance, early recognition and prompt management of neurologic injuries as 
they arise, may improve outcomes for patients on ECMO.
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